The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance

Chinese Medical Journal

Volumn 118, Issue 19, 2005, Pages 1615-1622

  Xie, Yi ^a   Jia, Wen Xiang ^a   Zeng, Wei ^a   Yang, Wei Qing ^a   Cheng, Xi ^a   Li, Xue Ru ^b   Wang, Lan Lan ^c   Kang, Mei ^c   Zhang, Zai Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SOUTHWEST JIAOTONG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Bacteria; Biofilms; Drug resistance; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; GREEN FLUORESCENT PROTEIN; POLITEF;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIUM ISOLATION; BIOFILM; COCULTURE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENE TRANSFER; NONHUMAN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SEQUENCE ANALYSIS;

BIOFILMS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 27144438293     PISSN: 03666999     EISSN: 03666999     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bush A, Accurso F, Macnee W, et al. Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004. Am J Respir Crit Care Med 2005; 171:545-553.
2. Ferkol TW, Look DC. Chinks in the armor of the airway: Pseudomonas infection in the cystic fibrosis lung. Am J Respir Cell Mol Biol 2001;25:11-13.
3. Barnard FM, Maxell A. Interaction between DNA gyrAse and quinolones: effects of alanine mutation at gyrA subunit residues Ser83 and Asp87. Antimicrob Agents Chemother 2001;45:1994-2000.
4. Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 2004;64:159-204.
5. Head NE, Yu H. Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect Immun 2004;72:133-144.
6. Sauer K, Camper AK, Ehilich GD, et al. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 2002; 184: 1140-1154.
7. Li XR, Jia WX, Yang C, et al. Study of type II topoisomerase mutation in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Chin J Antibiot (Chin) 2003;28:155-159.
8. Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263:802-805.
9. Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000;406:959-964.
10. McCaffrey C, Bertasso A, Pace J, et al. Quinolone Accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aures. Antimicrob Agents Chemother 1992;36:1601-1605.
11. Lomovskaya O, Warren MS, Lee A, et al. Identification and characterization of inhibitors of MDR efflux pumps in P. aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 2001;45:105-116.
12. Murray PR, Baron EJ, Jorgensen JH, et al. Antibacterial susceptibility tests: dilution methods. In: Murray PR, Baron EJ, Jorgensen JH, et al eds. Manual of Clinical Microbiology, 8th Edition. Washington, DC: American Society for Microbiology (ASM) Press; 2003:1231-1236.
13. Koenig GL. Viability of and plasmid retention in frozen recombinant Escherichia coli over time: a ten-year prospective study. Appl Envir Microbiol 2003;69:6605-6609.
14. Gillis RJ, Iglewski BH. Azithromycin retards Pseudomonas aeruginosa biofilm formation. J Clin Microbiol 2004;42:5842-5845.
15. Donlan RM. Biofilm: microbial life on surfaces. Emerg Infect Dis 2002;8:881-890.
16. Favre-Bonte S, Kohler T, Van Delden C. Biofilm formation by Pseudomonas aeruginosa: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin. J Antimicrob Chemother 2003;52:598-604.
17. Davies DG, Chakrabarty AM, Geesey GG. Exopolysaccharide production in biofilms: substratum action of alginate gene expression by P. aeruginosa. Appl Environ Microbiol 1993;59:1181-1186.
18. Pham TH, Webb JS, Rehm BH. The role of polyhydroxyalkanoate biosynthesis by Pseudomonas aeruginosa in rhamnolipid and alginate production as well as stress tolerance and biofilm formation. Microbiology 2004;150:3405-3413.
19. Kirisits MJ, Prost L, Starkey M, et al. Characterization of Colony Morphology Variants Isolated from Pseudomonas aeruginosa Biofilms. Appl Environ Microbiol 2005;71:4809-4821.
20. Sriramulu DD, Lunsdorf H, Lam JS, et al. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. J Med Microbiol 2005;54:667-676.
21. Nivens DE, Ohman DE, Williams J, et al. Role of alginate and its O acetylation in formation of Pseudomonas aeruginosa microcolonies and biofilms. J Bacteriol 2001;183:1047-1057.
22. Bagge N, Schuster M, Hentzer M, et al. Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and beta-lactamase and alginate production. Antimicrob Agents Chemother 2004;48:1175-1187.